Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease 论文
2020Nature Communications引用 561顶会
SARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsViral gastroenteritis research and epidemiology
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease · 相关事件
暂无数据